×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| AMBALAL SARABHAI ENTERPRISES L | 515.80 | 22.32 | 459.71 | 0.29 | 336.0 | 23.7 |
| Fredun Pharmaceuticals Limited | 1,026.97 | 53.33 | 1,018.41 | 11.29 | 328 | 17.5 |
| BROOKS LABORATORIES LTD. | 205.43 | -21.32 | 205.15 | -0.82 | 326 | 184.0 |
Ambalal Sarabhai Enterprise Ltd.,, with Security Code 500009, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.1 | 0.9 | 1.2 | 0.3 | 1.7 | 0.7 | 0.3 | 0.9 | 1.1 | 0.0 |
| Expenses | 2.6 | 2.2 | 2.3 | 1.7 | 4.9 | 2.1 | 2.0 | 1.6 | 2.4 | 1.8 |
| Operating Profit | -1.4 | -1.3 | -1.1 | -1.3 | -3.2 | -1.3 | -1.6 | -0.7 | -1.3 | 1.8 |
| OPM % | -119.87% | -141.33% | -91.86% | -350.54% | -184.86% | -167.21% | -499.08% | -67.31% | -110.6% | 1787% |
| Other Income | 2.4 | 2.0 | 2.8 | 2.6 | 1.2 | 2.0 | 1.3 | 3.4 | 1.9 | 6.4 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.9 | 0.6 | 1.6 | 2.0 | -2.0 | 0.6 | -0.4 | 2.7 | 0.5 | 8.0 |
| Tax % | 0.6% | 16.9% | 0.1% | 9.2% | 0% | 0% | -69.1% | 76.4% | 5.5% | 3.3% |
| Net Profit | 0.9 | 0.5 | 1.6 | 1.1 | -2.0 | 0.6 | -0.7 | 4.7 | 0.5 | 4.3 |
| EPS in Rs | 0.11 | 0.07 | 0.32 | 0.15 | -0.26 | 0.07 | -0.08 | 0.62 | 0.06 | 0.56 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.8 | 35.4 | 44.4 | 36.1 | 40.0 | 43.1 | 54.3 | 40.7 | 44.7 | 46.0 |
| Expenses | 46.1 | 33.8 | 41.1 | 40.1 | 39.0 | 40.6 | 49.7 | 40.2 | 42.2 | 46.7 |
| Operating Profit | 0.7 | 1.6 | 3.3 | -4.0 | 1.0 | 2.5 | 4.6 | 0.5 | 2.5 | -0.7 |
| OPM % | 1.6% | 4.4% | 7.5% | -11% | 2.5% | 5.9% | 8.5% | 1.2% | 5.7% | -1.5% |
| Other Income | 2.4 | 3.1 | 4.4 | 1.4 | 2.9 | 1.4 | 4.8 | 2.3 | 1.8 | 5.6 |
| Interest | 0.5 | 0.6 | 1.0 | 1.0 | 0.9 | 1.0 | 0.9 | 1.0 | 1.2 | 1.1 |
| Depreciation | 0.6 | 0.6 | 0.9 | 1.1 | 1.1 | 1.1 | 0.3 | 1.0 | 1.0 | 1.0 |
| Profit before tax | 2.0 | 3.4 | 5.8 | -4.6 | 1.8 | 1.8 | 8.3 | 0.8 | 2.1 | 2.8 |
| Tax % | 38.6% | 11.8% | 24.8% | -7.5% | 39.1% | 39.6% | 7.8% | 41.2% | 22.9% | 25.1% |
| Net Profit | 1.0 | 3.0 | 5.5 | -4.9 | 1.1 | 1.2 | 9.0 | 0.3 | 2.6 | 2.2 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 22% |
| 3 Years: | 44% |
| TTM: | 4213% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 18% |
| 3 Years: | 9% |
| 1 Year: | -27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 6% |
| 3 Years: | -22% |
| TTM: | 338% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 18% |
| 3 Years: | 9% |
| 1 Year: | -27% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|